Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process

被引:231
|
作者
Reeve, Emily [1 ,2 ,4 ]
Shakib, Sepehr [2 ]
Hendrix, Ivanka [3 ]
Roberts, Michael S. [4 ,5 ]
Wiese, Michael D. [1 ]
机构
[1] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5001, Australia
[2] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia
[3] Repatriat Gen Hosp, Dept Pharm, Daw Pk, SA, Australia
[4] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
[5] Univ Queensland, Sch Med, Therapeut Res Ctr, Brisbane, Qld, Australia
关键词
deprescribing; deprescribing process; elderly; inappropriate medication use; medication withdrawal; polypharmacy; RANDOMIZED CONTROLLED-TRIALS; ELDERLY-PATIENTS; DECISION-MAKING; DISCONTINUING MEDICATIONS; GENERAL-PRACTITIONERS; CONCEPTUAL-FRAMEWORK; OLDER PATIENTS; NURSING-HOMES; PATIENTS WANT; PRIMARY-CARE;
D O I
10.1111/bcp.12386
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inappropriate use of medication is widespread, especially in older people, and is associated with risks, including adverse drug reactions, hospitalization and increased mortality. Optimization of appropriate medication use to minimize these harms is an ongoing challenge in healthcare. The term 'deprescribing' has been used to describe the complex process that is required for safe and effective cessation of medication. Patients play an important role in their own health and, while they may complain about the number of medications they have to take, they may also be reluctant to cease a medication when given the opportunity to do so. A review of previously proposed deprescribing processes and relevant literature was used to develop the patient-centred deprescribing process, which is a five-step cycle that encompasses gaining a comprehensive medication history, identifying potentially inappropriate medications, determining whether the potentially inappropriate medication can be ceased, planning the withdrawal regimen (e.g. tapering where necessary) and provision of monitoring, support and documentation. This is the first deprescribing process developed using knowledge of the patients' views of medication cessation; it focuses on engaging patients throughout the process, with the aim of improving long-term health outcomes. Despite a comprehensive review of the literature, there is still a lack in the evidence base on which to conduct deprescribing. The next step in broadening the evidence to support deprescribing will be to test the developed process to determine feasibility in the clinical setting.
引用
收藏
页码:738 / 747
页数:10
相关论文
共 50 条
  • [11] Reducing inappropriate polypharmacy through a patient-centred, shared decision-making model of deprescribing
    Marques, I.
    Petty, D.
    Raynor, T.
    Blenkinsopp, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 12 - 13
  • [12] Evidence-Based Deprescribing of Statins in Patients With Advanced Illness
    Holmes, Holly M.
    Todd, Adam
    JAMA INTERNAL MEDICINE, 2015, 175 (05) : 701 - 702
  • [13] Deprescribing models: review of the evidence
    Marques, I.
    Petty, D.
    Raynor, T.
    Blenkinsopp, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 11 - +
  • [14] Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines
    Farrell, Barbara
    Richardson, Lisa
    Raman-Wilms, Lalitha
    de launay, David
    Alsabbagh, Mhd Wasem
    Conklin, James
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (01): : 18 - 25
  • [15] Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria
    Rodriguez-Perez, Aitana
    Rocio Alfaro-Lara, Eva
    Albinana-Perez, Sandra
    Dolores Nieto-Martin, Maria
    Diez-Manglano, Jesus
    Perez-Guerrero, Concepcion
    Santos-Ramos, Bernardo
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (11) : 2200 - 2207
  • [16] Development of an evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine
    Reeve, E.
    Farrell, B.
    Rockwood, K.
    Hilmer, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2018, 37 : 41 - 41
  • [17] Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
    Oldenburg, Lykke I. Kaas
    Dalin, Dagmar
    Drastrup, Anne Mette
    Vermehren, Charlotte
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2022, 5
  • [18] Improving the management of pain and cachexia in pancreatic cancer: Development of a patient-centred evidence-based pathway
    Postaleniec, Emilia
    Roberts, Danielle
    Saji, Alwin Puthiyakunnel
    Selvakumar, Jashan
    Ghahfarokhi, Mahta Haghighat
    Davidson, Brian
    Gurusamy, Kurinchi
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [19] A climate for evidence-based practice implementation in the patient-centred medical home
    Sklar, Marisa
    Hatch, Melissa R.
    Aarons, Gregory A.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2019, 25 (04) : 637 - 647
  • [20] Future of family medicine Role of patient-centred care and evidence-based medicine
    Premji, Kamila
    Upshur, Ross
    Legare, France
    Pottie, Kevin
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (05) : 409 - 412